Stock listing

NYKD Stock Price, News, Filings & Events — Nykode Therapeutics Asa

Selected listing: NYKD · OSL · NOK · NO

This page tracks Nykode Therapeutics Asa's NYKD:OSL listing on OSL in NOK for NO, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NYKD:OSL. NYKD:OSL is the stock-level entry point for investors researching Nykode Therapeutics Asa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nykode Therapeutics Asa is a public company listed on the Norwegian market under the ticker NYKD. The company has a market capitalization of approximately 104.4 million. Nykode focuses on developing innovative therapeutic solutions in the biotechnology sector.

NYKD:OSLNOKNOUpdated August 22, 2026
Nykode Therapeutics Asa logo
Ticker
NYKD:OSL
Asset type
Stock
Market cap
$143.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OSL
Currency
NOK

Nykode Therapeutics Asa NYKD:OSL stock context

This page tracks Nykode Therapeutics Asa's NYKD:OSL listing on OSL in NOK for NO, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NYKD:OSL. NYKD:OSL is the stock-level entry point for investors researching Nykode Therapeutics Asa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nykode Therapeutics Asa is a public company listed on the Norwegian market under the ticker NYKD. The company has a market capitalization of approximately 104.4 million. Nykode focuses on developing innovative therapeutic solutions in the biotechnology sector.

Latest news from Nykode Therapeutics Asa

All Nykode Therapeutics Asa news →

Nykode Therapeutics Asa earnings calls

Research Nykode Therapeutics Asa

Alternate listings